HomeTOP STORIESDyne Therapeutics rises on positive data from myotonic dystrophy trial Dyne Therapeutics rises on positive data from myotonic dystrophy trial By rogerjudd October 7, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleAdobe, GitLab slip as Mizuho sees ‘severe negative impact’ from AINext articleThe market looks calm on the surface, but paddling like a duck underneath – RBC Capital Markets’ Amy Wu Silverman latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
